| Deler fremragende | 16,253,332 shares |
| Insideraktier | 5.350.397 shares |
| Insider ejerskab | 32,92 % |
| Total Insiders | 30 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Jasper Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
LLP Abingworth
10% Owner -
|
5.628.558 | 1.066.189 | |
|
Amplitude Healthcare Holdings LLC
10% Owner -
|
2.300.000 | 230.000 | |
| Carlyle Group L.P. - | 1.066.189 | 1.066.189 | |
| Kenneth F Clifford - | 2.300.000 | 230.000 | |
| Peter R Dolan | 0 | ||
| Kurt Von Emster Director - [D] | 21.175 | 2.118 | |
| Fredric N Eshelman | 0 | ||
| Anna Louise French Director - [D] | 23.750 | 2.375 | |
|
Glazer Capital, Llc
10% Owner -
|
895.059 | 895.059 | |
|
Paul J Glazer
10% Owner -
|
895.059 | 895.059 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Howard I Hoffen - | 2.300.000 | 230.000 | |
| Heller Kevin N. | 7.500 | ||
| Vishal Kapoor Director - [D] | 87.500 | 8.750 | |
| Lawrence Otto Klein Director - [D] | 24.500 | 2.450 | |
| William Lis Director - [D] | 53.521 | 5.352 | |
| Ernest Mario | 0 | ||
| Ron Martell President, CEO & Director, Director - [D] [O] | 331.188 | 33.119 | |
|
Mark Mcdade
10% Owner -
|
5.852.982 | 851.965 | |
| Jeetinder Singh Mahal Chief Operating Officer - [O] | 25.009 | 25.009 | |
| Chris Nolet Director - [D] | 32.500 | 3.250 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Qiming U.S. Healthcare Fund II, L.P.
10% Owner -
|
8.519.648 | 851.965 | |
|
Qiming U.S. Healthcare GP II, LLC
10% Owner -
|
5.852.982 | 851.965 | |
|
Finance Ltd Roche
10% Owner -
|
4.624.606 | 454.961 | |
|
Holding Ltd Roche
10% Owner -
|
4.549.606 | 454.961 | |
| Glenn Reicin | 0 | ||
| Judith Anne Shizuru Director - [D] | 1.159.012 | 115.901 | |
| Edwin Jonathan Tucker Chief Medical Officer - [O] | 400 | 400 | |
|
Balaji Venkataraman
10% Owner -
|
2.300.000 | 1.188.500 | |
|
Velan Capital Investment Management LP
10% Owner -
|
1.188.500 | 1.188.500 | |
| Thomas G Wiggans Director - [D] | 50.000 | 5.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i JSPR / Jasper Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i JSPR / Jasper Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-12 | 2024-12-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 22,1100 | -900 | -20 | 25.009 | ||||
| 2024-12-12 | 2024-12-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 7,1000 | 900 | 6 | 25.909 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 21,2263 | -900 | -19 | 25.009 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 7,1000 | 900 | 6 | 25.909 | ||||
| 2024-06-12 | 2024-06-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 24,1550 | -900 | -22 | 25.009 | ||||
| 2024-06-12 | 2024-06-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 7,1000 | 900 | 6 | 25.909 | ||||
| 2024-06-10 | 2024-06-07 | 4 | Tucker Edwin Jonathan | JSPR | Voting Common Stock | D | 4,1735 | 400 | 2 | 400 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 26,4358 | -900 | -24 | 25.009 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 7,1000 | 900 | 6 | 25.909 | ||||
| 2024-02-12 | 2024-02-08 | 4 | Carlyle Group L.P. See footnotes | JSPR | Voting Common Stock | I | 12,9500 | 190.000 | 2.460 | 1.066.189 | ||||
| 2024-02-09 | 2024-02-08 | 4 | Velan Capital Investment Management LP By Velan Capital Master Fund LP | JSPR | Common Stock, par value $0.0001 per share | I | 12,9500 | 350.000 | 4.532 | 1.188.500 | ||||
| 2023-11-30 | 2023-11-28 | 4 | WIGGANS THOMAS G | JSPR | Voting Common Stock | D | 0,6486 | 10.000 | 6 | 50.000 | ||||
| 2023-11-22 | 2023-11-21 | 4 | WIGGANS THOMAS G | JSPR | Voting Common Stock | D | 0,6383 | 10.000 | 6 | 40.000 | ||||
| 2023-11-20 | 2023-11-20 | 4 | WIGGANS THOMAS G | JSPR | Voting Common Stock | D | 0,6309 | 10.000 | 6 | 30.000 | ||||
| 2023-11-20 | 2023-11-17 | 4 | WIGGANS THOMAS G | JSPR | Voting Common Stock | D | 0,5966 | 10.000 | 6 | 20.000 | ||||
| 2023-11-20 | 2023-11-16 | 4 | WIGGANS THOMAS G | JSPR | Voting Common Stock | D | 0,5965 | 10.000 | 6 | 10.000 | ||||
| 2023-10-13 | 2023-10-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 0,8500 | -37.126 | -32 | 250.097 | ||||
| 2023-10-13 | 2023-10-12 | 4 | MARTELL RON | JSPR | Voting Common Stock | D | 0,8500 | -87.531 | -74 | 331.188 | ||||
| 2023-10-13 | 2023-10-13 | 4 | Lis William | JSPR | Voting Common Stock | D | 0,8508 | -7.965 | -7 | 53.521 | ||||
| 2023-06-13 | 2023-06-13 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 1,6572 | -9.000 | -15 | 287.223 | ||||
| 2023-06-13 | 2023-06-13 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 0,7100 | 9.000 | 6 | 296.223 | ||||
| 2023-04-14 | 2023-04-14 | 4 | French Anna Louise | JSPR | Voting Common Stock | D | 1,4800 | -7.000 | -10 | 23.750 | ||||
| 2023-04-14 | 2023-04-13 | 4 | EMSTER KURT VON | JSPR | Voting Common Stock | D | 1,4903 | -9.075 | -14 | 21.175 | ||||
| 2023-04-14 | 2023-04-12 | 4 | MARTELL RON | JSPR | Voting Common Stock | D | 1,4600 | -87.531 | -128 | 418.719 | ||||
| 2023-04-14 | 2023-04-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 1,4600 | -37.126 | -54 | 287.223 | ||||
| 2023-04-14 | 2023-04-13 | 4 | Lis William | JSPR | Voting Common Stock | D | 1,4400 | -8.500 | -12 | 61.486 | ||||
| 2023-04-11 | 2023-01-27 | 4 | Qiming U.S. Healthcare Fund II, L.P. | JSPR | Voting Common Stock | D | 1,5000 | 2.666.666 | 4.000 | 8.519.648 | ||||
| 2023-02-27 | 3/A | Kapoor Vishal | JSPR | Voting Common Stock | D | 43.750 | ||||||||
| 2023-02-03 | 3 | Morgan Adam By Velan Capital Master Fund LP | JSPR | Common Stock, par value $0.0001 per share | I | 8.385.000 | ||||||||
| 2023-02-03 | 3 | Morgan Adam By Avego Healthcare Capital, L.P. | JSPR | Common Stock, par value $0.0001 per share | I | 2.453.281 | ||||||||
| 2023-01-31 | 2023-01-27 | 4 | Carlyle Group L.P. See footnotes | JSPR | Voting Common Stock | I | 1,5000 | 3.133.333 | 4.700 | 8.761.891 | ||||
| 2023-01-26 | 2023-01-25 | 4 | ROCHE HOLDING LTD | JSPR | Voting Common Stock | I | 1,8900 | -75.000 | -142 | 4.549.606 | ||||
| 2022-10-13 | 2022-10-12 | 4 | MARTELL RON | JSPR | Voting Common Stock | D | 506.250 | 506.250 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | Klein Lawrence Otto | JSPR | Voting Common Stock | D | 24.500 | 24.500 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | EMSTER KURT VON | JSPR | Voting Common Stock | D | 30.250 | 30.250 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | Shizuru Judith Anne | JSPR | Voting Common Stock | D | 29.500 | 1.159.012 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 214.722 | 324.349 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | Nolet Chris | JSPR | Voting Common Stock | D | 32.500 | 32.500 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | Lis William | JSPR | Voting Common Stock | D | 29.500 | 69.986 | ||||||
| 2022-10-13 | 2022-10-12 | 4 | French Anna Louise | JSPR | Voting Common Stock | D | 30.750 | 30.750 | ||||||
| 2022-08-11 | 3 | Carlyle Genesis UK LLC See footnotes | JSPR | Voting Common Stock | I | 5.628.558 | ||||||||
| 2022-06-28 | 2022-06-27 | 4 | Lis William | JSPR | Voting Common Stock | D | 2,0775 | -24.743 | -51 | 40.486 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Lis William | JSPR | Voting Common Stock | D | 2,0220 | -24.743 | -50 | 65.229 | ||||
| 2022-04-08 | 2022-04-07 | 4 | Mahal Jeetinder Singh | JSPR | Stock Option (right to buy) | D | 3,12 | 48.441 | 48.441 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Klein Lawrence Otto | JSPR | Stock Option (right to buy) | D | 3,54 | 78.045 | 78.045 | |||||
| 2022-03-23 | 2022-03-21 | 4 | MARTELL RON | JSPR | Stock Option (right to buy) | D | 3,54 | 1.704.328 | 1.704.328 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Heller Kevin N. | JSPR | Stock Option (right to buy) | D | 3,54 | 7.500 | 7.500 | |||||
| 2022-03-23 | 2022-03-21 | 4 | EMSTER KURT VON | JSPR | Stock Option (right to buy) | D | 3,54 | 78.045 | 78.045 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Shizuru Judith Anne | JSPR | Stock Option (right to buy) | D | 3,54 | 78.045 | 78.045 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Nolet Chris | JSPR | Stock Option (right to buy) | D | 3,54 | 78.045 | 78.045 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Mahal Jeetinder Singh | JSPR | Stock Option (right to buy) | D | 3,54 | 87.272 | 87.272 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Mahal Jeetinder Singh | JSPR | Stock Option (right to buy) | D | 3,54 | 7.500 | 7.500 | |||||
| 2022-03-23 | 2022-03-21 | 4 | French Anna Louise | JSPR | Stock Option (right to buy) | D | 3,54 | 78.045 | 78.045 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Lis William | JSPR | Stock Option (right to buy) | D | 3,54 | 100.000 | 100.000 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Lis William | JSPR | Stock Option (right to buy) | D | 3,54 | 89.972 | 89.972 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Lis William | JSPR | Stock Option (right to buy) | D | 3,54 | 7.500 | 7.500 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Lis William | JSPR | Voting Common Stock | D | 89.972 | 89.972 | ||||||
| 2022-03-23 | 2022-03-21 | 4 | Abingworth LLP See footnotes | JSPR | Stock Option (right to buy) | I | 3,54 | 78.045 | 78.045 | |||||
| 2021-10-04 | 3 | ROCHE FINANCE LTD | JSPR | Voting Common Stock | D | 4.624.606 | ||||||||
| 2021-10-01 | 3 | Abingworth LLP By Abingworth Bioventures VII, LP | JSPR | Common Stock | I | 5.628.558 | ||||||||
| 2021-10-01 | 3 | EMSTER KURT VON By Abingworth Bioventures VII, LP | JSPR | Common Stock | I | 5.628.558 | ||||||||
| 2021-10-01 | 3 | Shizuru Judith Anne | JSPR | Voting Common Stock | D | 1.129.512 | ||||||||
| 2021-10-01 | 3 | Mahal Jeetinder Singh | JSPR | Voting Common Stock | D | 109.627 | ||||||||
| 2021-10-01 | 3 | MCDADE MARK | JSPR | Voting Common Stock | D | 5.852.982 | ||||||||
| 2021-09-28 | 2021-09-24 | 4 | Amplitude Healthcare Holdings LLC | JSPR | Class B Common Stock | D | 2.300.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | Amplitude Healthcare Holdings LLC | JSPR | Class B Common Stock | D | 200.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | Amplitude Healthcare Holdings LLC | JSPR | Voting Common Stock | D | 2.300.000 | 2.300.000 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | VENKATARAMAN BALAJI | JSPR | Class B Common Stock | I | 2.300.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | VENKATARAMAN BALAJI | JSPR | Class B Common Stock | I | 200.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | VENKATARAMAN BALAJI | JSPR | Voting Common Stock | I | 2.300.000 | 2.300.000 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | HOFFEN HOWARD I | JSPR | Class B Common Stock | I | 2.300.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | HOFFEN HOWARD I | JSPR | Class B Common Stock | I | 200.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | HOFFEN HOWARD I | JSPR | Voting Common Stock | I | 2.300.000 | 2.300.000 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | Clifford Kenneth F | JSPR | Class B Common Stock | I | 2.300.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | Clifford Kenneth F | JSPR | Class B Common Stock | I | 200.000 | 0 | ||||||
| 2021-09-28 | 2021-09-24 | 4 | Clifford Kenneth F | JSPR | Voting Common Stock | I | 2.300.000 | 2.300.000 | ||||||
| 2021-04-23 | 2021-04-23 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 9,9200 | -151.719 | -1.505 | 895.059 | ||||
| 2021-04-23 | 2021-04-21 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 9,9200 | -1.164 | -12 | 1.046.778 | ||||
| 2021-04-21 | 2021-04-19 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 9,9700 | -2.060 | -21 | 1.047.942 | ||||
| 2021-02-22 | 2021-02-22 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,5000 | -698 | -7 | 1.050.002 | ||||
| 2021-02-22 | 2021-02-19 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,5000 | -2.112 | -22 | 1.050.700 | ||||
| 2021-02-22 | 2021-02-18 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,4500 | -10.000 | -104 | 1.052.812 | ||||
| 2021-02-09 | 2021-02-05 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,4000 | -212 | -2 | 1.062.812 | ||||
| 2021-01-19 | 2021-01-14 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,4000 | -101 | -1 | 1.063.024 | ||||
| 2021-01-12 | 2021-01-08 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,2500 | -10.000 | -102 | 1.063.125 | ||||
| 2020-12-31 | 2020-12-30 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,2500 | -75 | -1 | 1.073.125 | ||||
| 2020-12-31 | 2020-12-29 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,2500 | -18 | -0 | 1.073.200 | ||||
| 2020-12-28 | 2020-12-28 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,2000 | -10.000 | -102 | 1.073.218 | ||||
| 2020-12-28 | 2020-12-22 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,1500 | -10.000 | -102 | 1.083.218 | ||||
| 2020-12-15 | 2020-12-15 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,1500 | -10.000 | -102 | 1.093.218 | ||||
| 2020-12-15 | 2020-12-14 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,0500 | -5.000 | -50 | 1.103.218 | ||||
| 2020-12-15 | 2020-12-11 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,0500 | -5.000 | -50 | 1.108.218 | ||||
| 2020-12-09 | 2020-12-07 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,0500 | -1 | -0 | 1.113.218 | ||||
| 2020-12-09 | 2020-09-04 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A common stock, par value $0.0001 per share | I | 10,7300 | -11 | -0 | 1.113.219 | ||||
| 2020-09-23 | 2020-09-21 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 10,0000 | -1.000 | -10 | 1.113.230 | ||||
| 2020-09-18 | 2020-09-18 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 10,0000 | -1.000 | -10 | 1.114.230 | ||||
| 2020-09-18 | 2020-09-16 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -20 | -0 | 1.115.230 | ||||
| 2020-09-15 | 2020-09-15 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -800 | -8 | 1.115.250 | ||||
| 2020-09-15 | 2020-09-11 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -682 | -7 | 1.116.050 | ||||
| 2020-09-10 | 2020-09-08 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -1 | -0 | 1.116.732 | ||||
| 2020-08-17 | 2020-08-17 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -1.699 | -17 | 1.116.733 | ||||
| 2020-08-17 | 2020-08-13 | 4 | GLAZER CAPITAL, LLC See Footnote 1. | AMHC | Class A Common Stock | I | 9,9900 | -1.699 | -17 | 1.118.432 | ||||
| 2020-08-17 | 3 | GLAZER PAUL J See Footnote 1. | AMHC | Class A Common Stock | I | 1.120.131 | ||||||||
| 2020-01-07 | 2020-01-03 | 4 | Amplitude Healthcare Holdings LLC | AMHCU | Class B Common Stock | D | -375.000 | 2.500.000 | ||||||
| 2020-01-07 | 2020-01-03 | 4 | Clifford Kenneth F | AMHCU | Class B Common Stock | I | -375.000 | 2.500.000 | ||||||
| 2020-01-07 | 2020-01-03 | 4 | HOFFEN HOWARD I | AMHCU | Class B Common Stock | I | -375.000 | 2.500.000 | ||||||
| 2020-01-07 | 2020-01-03 | 4 | VENKATARAMAN BALAJI | AMHCU | Class B Common Stock | I | -375.000 | 2.500.000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
